Psychopharmacologia

, Volume 46, Issue 2, pp 219–222 | Cite as

Antinociceptive action of quipazine: Relation to central serotonergic receptor stimulation

  • R. Samanin
  • S. Bernasconi
  • A. Quattrone
Animal Studies

Abstract

Quipazine, a serotonin receptor stimulant, inhibited the response of rats to painful stimuli in two methods currently used to measure antinociception in these animals: the hot plate and tail compression test. The antinociceptive action was observed with doses ranging from 5 to 20 mg/kg i.p. according to the test situation.

The effect was significantly antagonized by a pretreatment with methergoline, a potent serotonin antagonist. An electrolytic lesion placed in the nucleus raphe medianus, which produced a marked decrease of serotonin in the forebrain did not, or only slightly, affected the effect of quipazine, depending on the method used to measure antinociception.

It is suggested that quipazine can produce antinociceptive action in rats by interacting with a serotonergic mechanism. The action appears to be due mainly to a direct action on postsynaptic serotonin receptors, although a presynaptic component can also contribute to the effect of quipazine.

Key words

Quipazine Antinociceptive action Serotonin Methergoline Midbrain raphe lesions 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akil, H., Mayer, D. J.: Antagonism of stimulation-produced analgesia by p-CPA, a serotonin synthesis inhibitor. Brain Res. 44, 692–697 (1972)Google Scholar
  2. Dahlström, A., Fuxe, K.: Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta physiol. scand. 62, suppl. 232, 1–55 (1964)Google Scholar
  3. Dandiya, P. C., Menon, M. K.: Studies on central nervous system depressants. III. Influence of some tranquilizing agents on morphine analgesia. Arch. int. Pharmacodyn. 141, 223–232 (1963)Google Scholar
  4. Eddy, N. B., Leimbach, D.: Synthetic analgesics. II. Diethienylbutenylamines and diethienylbutylamines. J. Pharmacol. exp. Ther. 107, 385–393 (1953)Google Scholar
  5. Giacalone, E., Valzelli, L.: A spectrofluorometric method for the simultaneous determination of 2-(5-hydroxyindol-3-yl) ethylamine (serotonin) and 5-hydroxyindol-3-yl-acetic acid in the brain. Pharmacology (Basel) 2, 171–175 (1969)Google Scholar
  6. Grabowska, M., Antkiewicz, L., Michaluk, J.: The influence of quipazine on the turnover rate of serotonin. Biochem. Pharmacol. 23, 3211–3212 (1974)Google Scholar
  7. Harvey, J. A., Lints, C. E.: Lesions in the medial forebrain bundle: relationship between pain sensitivity and telencephalic content of serotonin. J. comp. physiol. Psychol. 74, 28–36 (1971)Google Scholar
  8. Hong, E., Pardo, E. G.: On the pharmacology of 2-(1-piperazinyl) quinoline. J. Pharmacol. exp. Ther. 153, 259–265 (1966)Google Scholar
  9. Hong, E., Sancilio, L. F., Vargas, R., Pardo, E. G.: Similarities between the pharmacological actions of quipazine and serotonin. Europ. J. Pharmacol. 6, 274–280 (1969)Google Scholar
  10. König, J. F. R., Klippel, R. A.: The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. Baltimore: Williams & Wilkins 1963Google Scholar
  11. Liebeskind, J. C., Guibaud, G., Besson, J.-M., Oliveras, J.-L.: Analgesia from electrical stimulation of the periaqueductal gray matter in the cat: behavioral observations and inhibitory effects on spinal cord interneurons. Brain Res. 50, 441–446 (1973)Google Scholar
  12. Major, C. T., Pleuvry, B. J.: Effect of α-methyl-p-tyrosine, p-chlorophenylalanine; l-Β-(3,4-dihydroxyphenyl) alanine, 5-hydroxytryptophan and diethyldithiocarbamate on the analgesic activity of morphine and methylamphetamine in the mouse. Brit. J. Pharmacol. 42, 512–521 (1971)Google Scholar
  13. Mawson, C., Whittington, H.: Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Brit. J. Pharmacol. 39, 223 P (1970)Google Scholar
  14. Oliveras, J. L., Besson, J. M., Guibaud, G., Liebeskind, J. C.: Behavioral and electrophysiological evidence of pain inhibition from midbrain stimulation in the cat. Exp. Brain Res. 20, 32–44 (1974)Google Scholar
  15. Rodríguez, R., Pardo, E. G.: Quipazine, a new type of antidepressant agent. Psychopharmacologia (Berl.) 21, 89–100 (1971)Google Scholar
  16. Rodríguez, R., Rojas-Ramírez, J. A., Drucker-Colín, R. R.: Serotonin-like actions of quipazine on the central nervous system. Europ. J. Pharmacol. 24, 164–171 (1973)Google Scholar
  17. Samanin, R., Ghezzi, D., Mauron, C., Valzelli, L.: Effect of midbrain raphe lesion on the antinociceptive action of morphine and other analgesics in rats. Psychopharmacologia (Berl.) 33, 365–368 (1973)Google Scholar
  18. Samanin, R., Gumulka, W., Valzelli, L.: Reduced effect of morphine in midbrain raphe lesioned rats. Europ. J. Pharmacol. 10, 339–343 (1970)Google Scholar
  19. Samanin, R., Valzelli, L.: Increase of morphine-induced analgesia by stimulation of the nucleus raphe dorsalis. Europ. J. Pharmacol. 16, 298–302 (1971)Google Scholar
  20. Sparkes, C. G., Spencer, P. S. J.: Antinociceptive activity of morphine after injection of biogenic amines in the cerebral ventricles of the conscious rat. Brit. J. Pharmacol. 42, 230–241 (1971)Google Scholar
  21. Tenen, S. S.: Antagonism of the analgesic effect of morphine and other drugs by p-chlorophenylalanine, a serotonin depletor. Psychopharmacologia (Berl.) 12, 278–285 (1968)Google Scholar
  22. Vogt, M.: The effect of lowering the 5-hydroxytryptamine content of the rat spinal cord on analgesia produced by morphine. J. Physiol. (Lond.) 236, 483–498 (1974)Google Scholar
  23. Yarbrough, G. G., Buxbaum, D. M., Sanders-Bush, E.: Increased serotonin turnover in the acutely morphine treated rat. Life Sci. 10, pt. I, 977–983 (1971)Google Scholar

Copyright information

© Springer-Verlag 1976

Authors and Affiliations

  • R. Samanin
    • 1
  • S. Bernasconi
    • 1
  • A. Quattrone
    • 1
  1. 1.Istituto di Ricerche Farmacologiche “Mario Negri”MilanoItaly

Personalised recommendations